Dow Jones

39,036.14

-0.19%

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

INDV

Indivior (INDV)

Indivior PLC

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:INDV

1

Fecha	Hora	Fuente	Título	Símbolo	Compañía
18/06/2024	14:40	PR Newswire (US)	Indivior Announces the Publication of New Data on the Comparative Effectiveness of Intranasal (IN) Nalmefene (OPVEE 2.7mg) and IN Naloxone (4 mg) in a Translational Model Assessing the Impact of a Synthetic Opioid Overdose on Respiratory Depression and Car	NASDAQ:INDV	Indivior PLC
14/06/2024	07:47	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:INDV	Indivior PLC
10/06/2024	13:30	PR Newswire (US)	Indivior Announces Dosing of First Subject with INDV-2000 in a Phase 2 Study Assessing the Safety and Efficacy of INDV-2000 in Individuals with Opioid Use Disorder	NASDAQ:INDV	Indivior PLC
25/04/2024	01:00	PR Newswire (US)	Indivior Announces Q1 2024 Financial Results	NASDAQ:INDV	Indivior PLC
11/03/2024	13:43	PR Newswire (US)	Indivior Announces Publication Demonstrating that OPVEE® (nalmefene) Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone	NASDAQ:INDV	Indivior PLC
29/02/2024	01:02	PR Newswire (US)	Court Provides Final Approval of Settlement with Direct Purchaser Class in the Multidistrict Antitrust Litigation; Final Court Approval Concludes the Antitrust Multidistrict Litigation	NASDAQ:INDV	Indivior PLC
22/02/2024	01:00	PR Newswire (US)	Indivior Announces Q4 / FY 2023 Financial Results	NASDAQ:INDV	Indivior PLC
09/11/2023	01:05	PR Newswire (US)	Indivior Announces Q3 2023 Financial Results	NASDAQ:INDV	Indivior PLC
11/10/2023	15:20	PR Newswire (US)	Indivior Enters an Exclusive Licensing Agreement with Alar Pharmaceuticals	NASDAQ:INDV	Indivior PLC
26/09/2023	13:30	PR Newswire (US)	Indivior Publishes Real World Data Showing SUBLOCADE® May Reduce Non-Fatal Overdoses Among Individuals with Opioid Use Disorder in Canada	NASDAQ:INDV	Indivior PLC
21/08/2023	01:02	PR Newswire (US)	Indivior Reaches Agreement with End Payor Class to Resolve Their Antitrust Multi-District Litigation Claims	NASDAQ:INDV	Indivior PLC
27/07/2023	01:00	PR Newswire (US)	Indivior Announces Q2/H1 2023 Financial Results	NASDAQ:INDV	Indivior PLC
14/06/2023	12:53	PR Newswire (US)	Indivior Announces Four Abstracts Accepted for Presentation at the 85th Annual Scientific Meeting of the College on Problems of Drug Dependence	NASDAQ:INDV	Indivior PLC